LIA
LIMNW

Limestone Investment Advisors’s Liminatus Pharma Warrants LIMNW Stock Holding History

Limestone Investment Advisors’s Portfolio LIMNW Stock Details LIMNW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$902 Hold
22,562
– – ﹤0.01% 397
2025
Q4 		$790 Hold
22,562
– – ﹤0.01% 442
2025
Q3 		$3.34K Hold
22,562
– – ﹤0.01% 513
2025
Q2 		$5.41K Buy
+22,562
New +$4.43K ﹤0.01% 466

Other funds holding LIMNW

AC
Aristeia Capital Greenwich, Connecticut $4.82B AUM 24.91% 1-Year Est. Return
LA
Linden Advisors New York $17.9B AUM 1.72% 1-Year Est. Return
SCM
Saba Capital Management New York $3.62B AUM 12.96% 1-Year Est. Return
PAMP
Polar Asset Management Partners Toronto, Ontario, Canada $5.01B AUM 35.02% 1-Year Est. Return
MCM
Moore Capital Management New York $4.92B AUM 35.4% 1-Year Est. Return
MI
MMCAP International Grand Cayman, Cayman Islands $1.16B AUM 76.63% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
BOCH
Blue Owl Capital Holdings New York $372M AUM 78.25% 1-Year Est. Return
PC
Periscope Capital Toronto, Ontario, Canada $902M AUM 6.27% 1-Year Est. Return
WAM
Wolverine Asset Management Chicago, Illinois $10.4B AUM 4.78% 1-Year Est. Return

Limestone Investment Advisors's LIMNW Position: Q1 2026 in Review

Limestone Investment Advisors held its Liminatus Pharma Warrants (LIMNW) position steady in Q1 2026 at 22,562 shares worth $902. The position accounts for ﹤0.01% of the portfolio, ranked #397.

Limestone Investment Advisors first reported a position in LIMNW in Q2 2025 and has held it in 4 quarters since. The position peaked at $5.41K in Q2 2025. 21 funds tracked by Wall St. Rank hold LIMNW as of Q1 2026.

  • Limestone Investment Advisors held 22,562 shares of Liminatus Pharma Warrants worth $902 as of Q1 2026.
  • Limestone Investment Advisors left its Liminatus Pharma Warrants share count unchanged in Q1 2026.
  • Liminatus Pharma Warrants made up ﹤0.01% of Limestone Investment Advisors's portfolio in Q1 2026, its #397 holding.
  • Limestone Investment Advisors first reported a position in Liminatus Pharma Warrants in Q2 2025 and has held it in 4 quarters since.
  • Limestone Investment Advisors's Liminatus Pharma Warrants position peaked at $5.41K in Q2 2025.
  • 21 funds tracked by Wall St. Rank held Liminatus Pharma Warrants as of Q1 2026.

Based on Limestone Investment Advisors's 13F filing for Q1 2026, filed 15 May 2026.